S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
Free Trial

Syndax Pharmaceuticals (SNDX) SEC Filings & 10K Form

→ I’m officially sounding the alarm. (From Altimetry) (Ad)
Free SNDX Stock Alerts
$21.09
+0.60 (+2.93%)
(As of 10:04 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Recent Syndax Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
03/18/2024
6:10 AM		Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
4:21 PM		Syndax Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
4:28 PM		Syndax Pharmaceuticals (Filer)
Form S-3ASR
02/27/2024
3:33 PM		Syndax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
11:50 AM		Kynam Capital Management, LP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G
02/14/2024
6:01 AM		Point72 Asset Management, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
8:44 PM		Avidity Partners Management LP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
9:18 AM		Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/25/2024
10:20 AM		STATE STREET CORP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
12/20/2023
7:40 AM		Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
4:29 PM		Syndax Pharmaceuticals (Filer)
Form 424B5
12/15/2023
4:29 PM		Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
3:30 PM		Syndax Pharmaceuticals (Filer)
Form 424B5
10/05/2023
11:23 AM		Frazier Life Sciences Public Fund, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
10/02/2023
6:04 AM		Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
5:50 AM		Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
8:12 AM		Meury William (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2023
5:26 PM		Meury William (Reporting)
Syndax Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2023
6:07 AM		Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
8:23 AM		Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:12 PM		Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
3:20 PM		Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:32 PM		Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
3:39 PM		Syndax Pharmaceuticals (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:SNDX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company